Product Center
Hot Products
New RNA-Based Test Offers Hope in Global Tuberculosis Fight
April 30, 2025
Simpler, Faster Diagnostics Could Save Lives and Reduce Overtreatment 1.Tuberculosis: A Deadly but Treatable Disease In 2023, tuberculosis (TB) killed 1.25 million people worldwide. Despite being curable, TB remains the deadliest infectious disease. Powerful antibiotics can cure 88% of cases
Vaccine Breakthrough Offers Hope for Endangered California Condors
April 18, 2025
Bird Flu Vaccine Trial Shows Strong Immune Response, Averting a Conservation Crisis 1.A Race to Save North America’s Rarest Bird In 2023, a deadly strain of bird flu (HPAI) swept through California condor populations, killing 21 birds—nearly 18% of the
New Antibiotic Breakthrough Targets Drug-Resistant MRSA Infections
April 11, 2025
Lab-Developed Gel Could Revolutionize Treatment for Skin Superbugs 1.The Growing Threat of Antibiotic Resistance Superbugs are bacteria that resist common antibiotics. Every year, millions suffer from untreatable infections. MRSA, a deadly drug-resistant staph bacteria, is a major culprit. 2.A Promising
Study Finds Single Respiratory Virus May Cause Kawasaki Disease
March 28, 2025
Study Finds Single Respiratory Virus May Cause Kawasaki Disease New research from the Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago suggests that a single, unidentified respiratory virus may be the cause of
CDC Study Identifies Leading Causes of Foodborne Illness in the U.S.
March 25, 2025
A new study by the CDC reveals which foodborne pathogens are making Americans sick and how many people end up in the hospital or die. This study highlights the importance of advanced diagnostics in understanding the risks associated with foodborne
Vanderbilt’s $30M AI Mission: Faster, Smarter Antibody Therapies
March 18, 2025
1.AI vs Antibodies: A 30MQuest Vanderbilt University Medical Center(VUMC) has secured up to 30 million from the U.S. government’s ARPA-H to revolutionize antibody therapy development using artificial intelligence. The project aims to create an AI-driven platform capable of designing antibodies
Scientists Discover New Strategy to Combat Norovirus
March 7, 2025
1.A Breakthrough in Fighting a Global Threat Scientists at The University of Texas at Austin, alongside researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have uncovered a promising strategy to fight norovirus.
Synthetic Microbiome Therapy: A Breakthrough Against Dangerous Gut Infections
March 4, 2025
1.A New Approach to Fighting Stubborn Infections A synthetic microbiome therapy shows promise in fighting dangerous gut infections. Tested in mice, it combats Clostridioides difficile (C. difficile), a stubborn and potentially deadly bacterium. Researchers at Penn State developed this treatment
Study Shows How Herpes Viruses Contribute to Alzheimer’s Disease in Aging Brains
February 28, 2025
Researchers from Cleveland Clinic’s Genome Center have discovered that the herpes simplex virus-1 (HSV-1) may contribute to Alzheimer’s disease in aging brains. Their study, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, suggests that two FDA-approved drugs
New Mpox Variant Spreads Faster Across Borders
February 23, 2025
International researchers, including experts from the DTU National Food Institute, have warned that a new variant of mpox could spread quickly across borders. This new variant, called clade 1b, has mutated, making it more infectious. 1.Clade 1b’s Rise and Spread
Prozac May Help Treat Sepsis by Boosting the Immune System
February 20, 2025
Prozac, a common antidepressant, is known for treating mental health issues, but recent studies show it may also help fight serious infections and sepsis. Scientists at the Salk Institute discovered how Prozac can boost the immune system, providing protection against
Breakthrough Malaria Vaccine: One Dose for High-Level Protection
February 16, 2025
Scientists at Sanaria and Seattle Children’s Research Institute’s Center for Global Infectious Disease Research (CGIDR) have introduced an exciting malaria vaccine, the Sanaria® PfSPZ-LARC2. This new vaccine offers high-level protection with just one dose. It uses decades of research and
